Managing malignant disease in patients with porphyria.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*; D011164:Porphyrias / Q000150:complications* / Q000628:therapy
D000970:Antineoplastic Agents